F
Freenome
Outpacing cancer starts with early detection
About Freenome
Freenome is a biotechnology company developing blood-based tests to detect cancer in its earliest, most treatable stages. It uses a multiomics platform combined with artificial intelligence and machine learning, and offers a portfolio of SimpleScreen blood-based screening tests (including colorectal cancer and lung tests).
Industry
Biotechnology Research
Headquarters
Brisbane, California
Company size
201-500
Founded
2014
What we do
molecular diagnosticsmultiomicsmachine learningearly cancer detectionblood-based cancer screening
Interested in Freenome?
Join our talent pool to be considered for future opportunities.